{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih34ivzvfuphhypk3j6543kihxubl5cucahp5pis4vkr2bzlhhfh4",
    "uri": "at://did:plc:4kwqvtwyj7nywt3v7ra2cuy4/app.bsky.feed.post/3mf5n4gobno62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidxzgxebpwx64rkkwt54qmncz44ibi54bnlzsjz66elzmqnha4aki"
    },
    "mimeType": "image/jpeg",
    "size": 609303
  },
  "path": "/content/700beae3-8ead-4833-840b-319de233ce9b",
  "publishedAt": "2026-02-18T15:29:38.000Z",
  "site": "https://www.ft.com",
  "textContent": "U-turn comes after backlash from the company and US biotech industry",
  "title": "Trump administration reverses move to block Moderna flu vaccine trial"
}